We are live on ! Find out more
OPRX icon

OptimizeRx

121 hedge funds and large institutions have $568M invested in OptimizeRx in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

438% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 8

326% more call options, than puts

Call options by funds: $44.1M | Put options by funds: $10.3M

109% more capital inflows, than outflows

Capital inflows: $152M | Capital outflows: $72.6M

41% more funds holding

Funds holding: 86 → 121 (+35)

2.96% more ownership

Funds ownership: 66% → 68.96% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

6% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 36

Holders
121
Holders Change
+35
Holders Change %
+40.7%
% of All Funds
2.12%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
43
Increased
34
Reduced
36
Closed
8
Calls
$44.1​M
Puts
$10.3​M
Net Calls
+$33.8​M
Net Calls Change
+$27.7​M

OPRX Hedge Fund Activity: Q1 2021 in Review

121 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2021, worth a combined $568M — up 83% from $311M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new OPRX positions and 8 closed out — a net gain of 35 holders — while 34 added to existing stakes and 36 trimmed.

The largest buyer was Artisan Partners, opening a new position worth an estimated $37.3M. The largest seller was AWM Investment Company, cutting an estimated $9.6M.

  • 121 institutional investors held OptimizeRx (OPRX) as of Q1 2021, up from 86 in Q4 2020.
  • Funds reported $568M of OptimizeRx stock for Q1 2021, up 83% quarter-over-quarter.
  • 43 funds opened new OptimizeRx positions in Q1 2021 and 8 closed out, a net change of +35 holders.
  • The largest OptimizeRx buyer in Q1 2021 was Artisan Partners, an estimated $37.3M added.
  • The largest OptimizeRx seller in Q1 2021 was AWM Investment Company, an estimated $9.6M sold.

Based on aggregated 13F filings for Q1 2021.